
Antidepressants & Supplementations
Important Drug Interactions

Many adults take antidepressants for depression, anxiety, or chronic pain—often alongside over-the-counter supplements. While some supplements can enhance well-being or reduce side effects, others may interfere with medications, cause dangerous interactions, or worsen symptoms.
Why Interactions Matter
Antidepressants—including SSRIs, SNRIs, MAOIs, tricyclics, and atypical antidepressants—affect neurotransmitters like serotonin, norepinephrine, dopamine, and GABA.
Certain supplements also influence these systems, and may:
-
Increase the risk of serotonin syndrome
-
Alter drug metabolism via liver enzymes (e.g., CYP450)
-
Counteract or amplify the antidepressant’s effect
-
Increase sedation, agitation, or blood pressure
⚠️ High-Risk Supplements (Avoid or Use With Extreme Caution)
1. St. John's Wort
-
Often used for mild depression.
-
Strongly contraindicated with SSRIs, SNRIs, tricyclics, and MAOIs.
-
Can cause serotonin syndrome, reduce antidepressant levels, or worsen anxiety due to enzyme induction (Izzo & Ernst, 2009).
2. 5-HTP and L-Tryptophan
-
Precursors to serotonin.
-
May amplify serotonergic activity and trigger serotonin syndrome when taken with SSRIs, SNRIs, or MAOIs (Birdsall, 1998).
3. SAMe (S-Adenosylmethionine)
-
Has antidepressant properties.
-
Can augment mood but also trigger manic episodes or serotonin syndrome if combined with SSRIs/SNRIs (Papakostas et al., 2010).
-
Use only under psychiatric supervision.
4. Melatonin (high doses)
-
Can cause daytime drowsiness, interfere with sleep cycles, or compound sedation from antidepressants like trazodone or mirtazapine.
-
May also blunt SSRI-induced REM effects (Shin et al., 2020).
✅ Supplements Often Considered Safe (With Consultation)
1. Omega-3 Fatty Acids (EPA/DHA)
-
Anti-inflammatory; may enhance antidepressant efficacy, especially for depressive symptoms (Guu et al., 2019).
-
No known serious drug interactions.
-
Safe adjunct with SSRIs/SNRIs when dosed appropriately (1–2 g/day EPA).
2. Vitamin D
-
Often low in people with depression.
-
Supports immune and brain health, with no major interaction risks.
-
Can be safely used alongside antidepressants, especially if deficient (Menon et al., 2020).
3. Magnesium
-
Helps reduce anxiety, irritability, and sleep disturbance.
-
Generally safe; may support SSRI or SNRI use.
-
Large doses may cause diarrhea or interact with lithium clearance.
4. B Vitamins (especially B6, B9/folate, B12)
-
Involved in mood, methylation, and neurotransmitter synthesis.
-
Can be safe and supportive, particularly in those with deficiencies.
-
No major interactions—but caution with high-dose B6 due to potential neuropathy.
⚠️ Cautionary Supplements (Use Case-by-Case)
1. Ashwagandha: May cause sedation or thyroid effects. Caution if on sedating antidepressants.
2. Rhodiola rosea: May amplify stimulatory effects. Risk of agitation with activating antidepressants.
3. Valerian root: Sedating, may cause excessive drowsiness. Avoid combining with trazodone, mirtazapine and TCAs.
4. CBD oil: Alters CYP450 enzymes. Can change blood levels of antidepressants.
5. Kava: Hepatotoxic, sedating. Not recommended with any psychotropics.
Serotonin Syndrome: Know the Warning Signs
-
A rare but serious condition caused by excess serotonin. It can happen when antidepressants are combined with other serotonergic supplements or drugs.
🛑 Watch for:
-
Restlessness, agitation, confusion
-
Rapid heart rate, high blood pressure
-
Sweating, tremor, muscle rigidity
-
Diarrhea, fever
Seek immediate medical attention if these occur while taking serotonergic agents.
While some supplements can complement antidepressant therapy, others pose serious risks—especially those that affect serotonin or sedation. The safest route is to discuss any supplement with your doctor or psychiatrist before use.
References:
-
Birdsall, T. C. (1998). 5-Hydroxytryptophan: A clinically-effective serotonin precursor. Alternative Medicine Review, 3(4), 271–280.
-
Guu, T. W., Mischoulon, D., Sarris, J., et al. (2019). Efficacy of omega-3 PUFAs in depression: A meta-analysis. Journal of Clinical Psychiatry, 80(6), 18r12491. https://doi.org/10.4088/JCP.18r12491
-
Izzo, A. A., & Ernst, E. (2009). Interactions between herbal medicines and prescribed drugs: A systematic review. Drugs, 69(13), 1777–1798. https://doi.org/10.2165/11317010-000000000-00000
-
Menon, V., Kar, S. K., & Suthar, N. (2020). Vitamin D and depression: A critical review of literature. Indian Journal of Psychological Medicine, 42(1), 11–21. https://doi.org/10.4103/IJPSYM.IJPSYM_353_19
-
Papakostas, G. I., Mischoulon, D., Shyu, I., et al. (2010). S-Adenosyl Methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant non-responders with major depressive disorder: A double-blind, randomized clinical trial. American Journal of Psychiatry, 167(8), 942–948. https://doi.org/10.1176/appi.ajp.2010.09081198
-
Shin, Y. K., Kim, D. W., Park, J. W., et al. (2020). The effect of melatonin on depressive symptoms and sleep disturbance in patients taking SSRIs. Sleep Medicine, 67, 154–160. https://doi.org/10.1016/j.sleep.2019.10.009